Biofrontera Inc. (BFRI)
BFRINASDAQ-CMBiotechnology: Pharmaceutical Preparations
$0.8875
+0.0595 (+7.19%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $13.18m
- P/E
- –
- EPS, last 4 quarters
- $-0.5500
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.5547 to $1.66
- Average volume
- 445.7k
- Previous close
- $0.8280
Earnings
next estimate $-0.3300Next report Nov 11, 2026
Sep 2025
+1.7%
Dec 2025
+72.4%
Mar 2026
-127.8%
Jun 2026
+70.6%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $6.99m | $17.10m | $10.08m | $12.00m |
| Gross profit | $4.94m | $14.09m | $7.97m | $9.59m |
| Operating income | -$6.28m | $4.56m | -$4.32m | -$524.0k |
| Net income | -$6.65m | $5.64m | -$4.75m | -$604.0k |
Last four quarters: revenue $46.17m, margin -13.8%, free cash flow –
News
8 latest- MannKind (MNKD) Reports Q3 Loss, Misses Revenue EstimatesZacks · 4 days ago
- Biofrontera Files SNDA To Expand Ameluz Use In Actinic Keratosis; Stock Down RTTNews · Oct 8, 2026
- Biofrontera Submits Ameluz SNDA For Expanded Actinic Keratosis Use RTTNews · Oct 8, 2026
- Biotech Stocks In Focus - IMCC +245%, XRTX +12%, SILO, BFRI RTTNews · Sep 18, 2026
- Biofrontera Stock Drops 6% Despite Securing FDA Approval For Ameluz SNDA RTTNews · Sep 14, 2026
- ISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA Decision RTTNews · Sep 8, 2026
- Biotech Stocks At 52-Week Highs - PDEX +18% On FY'26 Results, ODTX +8%, EOLS, BFRI, DRTS RTTNews · Sep 7, 2026
- Biotech Stocks At 52-Week Highs - RNXT +12%, BLSM, RVTY, ATRC, BFRI RTTNews · Aug 31, 2026
The company
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with photodynamic therapy (PDT). The Company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, and superficial basal cell carcinoma, and are in development for additional indications. For more information, visit www.biofrontera-us.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- biofrontera-us.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.